Company Filing History:
Years Active: 2009-2010
Title: Christian Devaux: Innovator in Antiviral Research
Introduction
Christian Devaux is a notable inventor based in Montpellier, France. He has made significant contributions to the field of antiviral research, particularly in the development of novel drugs targeting HIV. With a total of 2 patents, his work is recognized for its potential impact on treating multidrug-resistant HIV infections.
Latest Patents
One of his latest patents is titled "Antiviral peptides obtained from the tryptophan-rich hydrophobic cluster of the HIV-1 reverse transcriptase." This invention focuses on a new class of drugs aimed at combating HIV. It comprises a peptide or analog that includes a decapeptide with specific amino acid arrangements designed to enhance its efficacy against the virus.
Another significant patent is "Mutant Fab fragments of the chimeric 13B8.2 anti-CD4 antibody and their applications." This patent describes a mutant Fab fragment of the 13B8.2 anti-CD4 antibody that binds to the CD4 molecule. It includes mutations in the variable domains of the heavy and light chains, which may improve its therapeutic applications.
Career Highlights
Christian Devaux is affiliated with the Centre National de la Recherche Scientifique, where he conducts his research. His work has been instrumental in advancing the understanding of antiviral mechanisms and developing innovative treatment options for HIV.
Collaborations
He has collaborated with notable colleagues, including Cédric Bes and Laurence Briant-Longuet. Their combined expertise has contributed to the success of their research initiatives.
Conclusion
Christian Devaux's innovative work in antiviral research highlights his commitment to addressing critical health challenges. His patents reflect a promising future in the fight against HIV, showcasing the importance of continued research and collaboration in this vital field.